CYP2C9 and Thromboembolism: CYP2C9 enzyme plays a very important role in the metabolism of vitamin K antagonist anticoagulants, such as S-warfarin, S-acenocoumarol, and phenprocoumon, commonly used to treat thromboembolic diseases (Daly and King, 2006; Chen et al., 2018).